Insulet Corporation

GOV.F·Frankfurt·Healthcare
Compare
146.10−0.65 (−0.44%)today
As of Nov 5, 8:10 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close146.75
Open146.10
Day range—
52-week range112.45304.00
Off day high0.00%
Off 52-week high−51.94%
Volume40.00
Avg. volume (3M)25.00
Market cap10.13B
EPS (TTM)4.95
Forward P/E94.26
P/E ratio (TTM)29.52
Dividend yield—
Beta (5Y)1.05
Shares outstanding69.35M
Short interest—
Earnings dateNov 4, 2026
Analyst target—
Profit margin12.29%

Against its peers

Compare in full ›
GOV.F BBNX TNDM 2235.HK HAE AHCO
Market cap 10.13B 921.52M 1.33B 2.62B 5.80B 975.22M
P/E (TTM) 29.5 — — 28.9 61.6 —
Forward P/E 94.3 -7.8 119.8 18.9 22.1 -40.6
Price/book 7.6 2.3 10.2 1.2 6.9 0.8
Dividend yield — — — — — —
1-year change −49.47% −43.04% +20.31% −4.24% +137.15% −23.93%
Today −0.44% +12.25% +7.93% −0.30% +5.94% +16.40%

The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.

Latest news

All GOV.F news ›
TradingView·Positive

Insulet (PODD) Q3 earnings: what to expect

Insulin delivery company Insulet Corporation PODD will be reporting earnings this Wednesday morning. Here’s what to expect. Insulet beat analysts’ revenue expectations last quarter, reporting revenues of $801.7 million, up 23.5% year on…

@law360·Negative

Insulet Can't Keep Injunction During Trade Secret Appeal

The Federal Circuit has denied insulin product developer Insulet Corp.'s request to keep an injunction in place against rival EOFlow Co. Ltd. while it appeals an axed $59 million trade secrets jury verdict to the U.S. Supreme Court.…

NVS
Life Sciences IP Review·Negative

Fed Circ refuses to rehear Insulet’s $59.4m trade secret loss

Life Sciences IP Review - Fed Circ refuses to rehear Insulet’s $59.4m trade secret loss A panel rejected the Omnipod maker’s request for a rehearing in its trade secrets dispute with South Korean insulin pump maker EOFlow, leaving in pl

openPR.com·Positive

Diabetes Devices Market to Grow at 6% CAGR During 2026-2031 | Top Manufacturers; Medtronic Plc, Abbott Laboratories, F.Hoffmann-LA Roche Ltd, Dexcom Inc, Arkray Inc., Eli Lily & Company, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed, Ascensia Di

Press release - Meditechinsights - Diabetes Devices Market to Grow at 6% CAGR During 2026-2031 | Top Manufacturers; Medtronic Plc, Abbott Laboratories, F.Hoffmann-LA Roche Ltd, Dexcom Inc, Arkray Inc., Eli Lily & Company, Insulet…

From the 4Search news index, newest first.

In the news

11mentions in 30 days
11with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance